Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00404872 · ClinicalTrials.gov registry record
Evaluating the Relationship Between Fatty Acids and Heart Disease
A clinical trial, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 4,766
- Enrollment target
NCT00404872 is a clinical trial that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 4,766 participants.
The verdict
NCT00404872 has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 4,766 participants
- Enrollment target
Study Summary
Cardiovascular disease (CVD) affects millions of people in the United States; each year, more people die from CVD than from any other disease. Individuals with low levels of n-3 fatty acids and high levels of trans-fatty acids may have an increased risk of developing CVD. This study will evaluate the link between fatty acids and the presence of CVD in older adults.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,766 participants |
| Start Date | 1989-01 |
| Est. Completion | 2006-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00404872
The ClinicalTrials.gov registry entry for NCT00404872 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4,766 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00404872 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00404872 about?
NCT00404872 is a clinical study titled "Evaluating the Relationship Between Fatty Acids and Heart Disease". Cardiovascular disease (CVD) affects millions of people in the United States; each year, more people die from CVD than from any other disease. Individuals with low levels of n-3 fatty acids and high levels of trans-fatty acids may have an increased risk of developing CVD. This study will evaluate th...
What is the current status of trial NCT00404872?
This trial is currently completed. The enrollment target is 4,766 participants. The study started on 1989-01. Estimated completion is 2006-06.
Who is sponsoring clinical trial NCT00404872?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.